The trial on 80 MS patients will test whether bone marrow stem cells, which can repair tissue and organ damage, can be used to treat the disease.
Scotland has one of the highest rates of MS in the world and around 10,500 people north of the Border have the condition, which is most commonly diagnosed between the ages of 20 and 40 and is more prevalent among women than men.
